International Patent: OCTAHYDRO-1H-ISOINDOLE-HETEROBICYCLIC JAK-BTK INHIBITORS AND METHODS OF USE THEREOF

GENEVA, Oct. 5 -- CELLARITY, INC. filed a patent application (IB2026/053064) for “OCTAHYDRO-1H-ISOINDOLE-HETEROBICYCLIC JAK-BTK INHIBITORS AND METHODS OF USE THEREOF”. With publication no. WO/2026/202854, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 487/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....